Lindbrook Capital’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$488 Sell
45
-7
-13% -$70 ﹤0.01% 2625
2024
Q4
$495 Sell
52
-14
-21% -$142 ﹤0.01% 2627
2024
Q3
$741 Sell
66
-87
-57% -$925 ﹤0.01% 2572
2024
Q2
$1.53K Hold
153
﹤0.01% 2411
2024
Q1
$1.76K Sell
153
-167
-52% -$1.42K ﹤0.01% 2289
2023
Q4
$2.33K Buy
+320
New +$2.52K ﹤0.01% 2211
2023
Q3
Sell
-59
Closed -$718 2686
2023
Q2
$718 Sell
59
-51
-46% -$568 ﹤0.01% 2433
2023
Q1
$1.37K Sell
110
-309
-74% -$5.68K ﹤0.01% 2381
2022
Q4
$8.05K Hold
419
﹤0.01% 1544
2022
Q3
$8K Buy
419
+294
+235% +$6.04K ﹤0.01% 1396
2022
Q2
$2K Buy
+125
New +$2.03K ﹤0.01% 1895

Other funds holding AHCO

Lindbrook Capital's AHCO Position: Q1 2025 in Review

Lindbrook Capital reduced its AdaptHealth (AHCO) stake by 13% in Q1 2025, selling an estimated $70 and leaving 45 shares worth $488. The position accounts for ﹤0.01% of the portfolio, ranked #2625.

Lindbrook Capital first reported a position in AHCO in Q2 2022 and has held it in 11 quarters since. The position peaked at $8.05K in Q4 2022. 226 funds tracked by Wall St. Rank hold AHCO as of Q1 2025.

  • Lindbrook Capital held 45 shares of AdaptHealth worth $488 as of Q1 2025.
  • Lindbrook Capital sold 7 AdaptHealth shares in Q1 2025, an estimated $70.
  • AdaptHealth made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2625 holding.
  • Lindbrook Capital first reported a position in AdaptHealth in Q2 2022 and has held it in 11 quarters since.
  • Lindbrook Capital's AdaptHealth position peaked at $8.05K in Q4 2022.
  • 226 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.